FDA

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Jan. 28) 10X Genomics Inc (NASDAQ: TXG) Acceleron Pharma Inc (NASDAQ: XLRN) (announced positive Phase 2 results for its pulmonary hypertension drug)...

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Jan. 27) 10X Genomics Inc (NASDAQ: TXG) Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN)(announced early termination of waiting period for its proposed...

Biotech stocks haven't seen much of a momentum thus far in the new year amid a lack of meaningful catalysts. The bygone week saw two FDA approvals: Horizon Therapeutics PLC's (NASDAQ: HZNP) thyroid eye disorder drug and Epizyme Inc's (NASDAQ: EPZM) tazemetostat for epithelioid...

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Jan. 23) Baudax Bio Inc (NASDAQ: BXRX) Mesoblast limited (NASDAQ: MESO) Nevro Corp (NYSE: NVRO) Oyster Point Pharma Inc (NASDAQ: OYST) Soligenix, Inc. (...

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Jan. 22) 10X Genomics Inc (NASDAQ: TXG) Abbott Laboratories (NYSE: ABT)(reported strong fourth-quarter results and issued in-line guidance) Apellis...

Former FDA Commissioner Scott Gottlieb said Tuesday afternoon on CNBC the coronavirus "so far seems to be a mild illness." The total reported cases rose to 440 in China with nine confirmed fatalities, at time of publication Wednesday afternoon. Gottlieb: Not That Serious The current...

McDonald's Corp (NYSE: MCD) is testing a new chicken sandwich across three states and the National Owners Association is urging McDonald's franchise owners not to "get distracted" with inaccurate media reports concerning MSG. What Happened With McDonald's The National Owners...

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Jan. 21) Abbott Laboratories (NYSE: ABT) Apellis Pharmaceuticals Inc (NASDAQ: APLS) Aptose Biosciences Inc (NASDAQ: APTO) AtriCure Inc. (NASDAQ: ATRC)...

Shares of thinly-traded gene therapy company Genprex Inc (NASDAQ: GNPX) are soaring on more than 50 times their average volume Tuesday. What Happened Genprex, which uses a non-viral, proprietary platform to deliver tumor suppressor genes to cancer cells, said the FDA has granted Fast Track...

Biotech news flow remained light last week, although there were some notable developments such as FDA panel reviews of opioid pain drugs, a few clinical data readouts, presentations and updates at the JPMorgan Healthcare conference. Here are the key catalysts that could prove market moving in the...

The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs on Jan. 16.) Acceleron Pharma Inc (NASDAQ: XLRN) Aimmune Therapeutics Inc (NASDAQ: AIMT) Arvinas Inc (NASDAQ: ARVN) AtriCure Inc. (NASDAQ: ATRC)...

On Wednesday, members of the House Energy and Commerce Subcommittee on Health held a hearing titled “Cannabis Policies for the New Decade." In the committee’s first ever hearing on marijuana reform, members of the House listened to the testimony of three witnesses: Matthew J....

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Jan. 15) 10X Genomics Inc (NASDAQ: TXG) Aimmune Therapeutics Inc (NASDAQ: AIMT) Allergan plc (NYSE: AGN) Apellis Pharmaceuticals Inc (NASDAQ: APLS)...

Kuala Lumpur-based budget carrier AirAsia Berhad (OTC: AIABF) has partnered with Alphabet Inc. (NASDAQ: GOOGL) (NASDAQ: GOOG) to launch a technology academy, CNBC reported on Wednesday. What Happened The "AirAsia Google Cloud Academy" will be managed by AirAsia's venture fund RedBeat...

Clovis Oncology Inc (NASDAQ: CLVS) shares are advancing strongly after the company clinched a regulatory milestone with respect to its oncology drug Rubraca. The Boulder, Colorado-based biopharma company that focuses on the development of anti-cancer agents said the FDA has accepted its sNDA for...